Anchen Acquisition (Anchen Acquisition [Member])

6 Months Ended

Jun. 30, 2012

Anchen Acquisition [Member]

Business Acquisition [Line Items]

Anchen Acquisition

Note 2 – Anchen Acquisition:

On November 17, 2011, through Par Pharmaceutical, Inc., our wholly-owned subsidiary, we completed our acquisition of Anchen Incorporated and its subsidiary Anchen Pharmaceuticals, Inc. (collectively referred to as “Anchen”) for $412,753 thousand in aggregate consideration (the “Anchen Acquisition”), subject to post-closing adjustment. During the second quarter of 2012, we collected $3,786 thousand as a result of post-closing adjustments with the former Anchen securityholders and adjusted goodwill associated with the Anchen Acquisition as of June 30, 2012. We also believe the purchase price allocation is final.